Cargando…

Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus

The purpose of the present study was to determine the potential relationships of glycemic control and use of metformin with non-muscle invasive bladder cancer characteristics. We reviewed data from 645 patients with non-muscle invasive bladder cancer between January 2004 and May 2015. We analyzed th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Ji Hoon, Jung, Seung Il, Yim, Sang Un, Kim, Sun Woo, Hwang, Eu Chang, Kwon, Dong Deuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974190/ https://www.ncbi.nlm.nih.gov/pubmed/27510392 http://dx.doi.org/10.3346/jkms.2016.31.9.1464

Ejemplares similares

Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells
por: Hwang, Eu Chang, et al.
Publicado: (2017)

Role of oral pentosan polysulfate in Bacillus Calmette–Guérin therapy in patients with non-muscle-invasive bladder cancer
por: Lee, Ho Yeon, et al.
Publicado: (2022)

Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
por: Huang, Wei-Lun, et al.
Publicado: (2020)

Metformin for the Prevention of Bladder Cancer Recurrence: Is it Effective?
por: Heidari, Fatemeh, et al.
Publicado: (2016)

Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus
por: Cho, Young Min, et al.
Publicado: (2010)

No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
por: Evers, Jelle, et al.
Publicado: (2020)

A novel transurethral resection technique for superficial flat bladder tumor: Grasp and bite technique
por: Oh, Kyung Jin, et al.
Publicado: (2015)

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Han, Mi Ah, et al.
Publicado: (2021)

Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study
por: Kim, Hyung Suk, et al.
Publicado: (2016)

Fibroepithelial Polyp Mimicking a Renal Pelvis Tumor
por: Hwang, Eu Chang, et al.
Publicado: (2013)

Prevalence of Antibiotic-Resistant Bacteria on Rectal Swabs and Factors Affecting Resistance to Antibiotics in Patients Undergoing Prostate Biopsy
por: Kim, Jong Beom, et al.
Publicado: (2014)

Clinical factors associated with postoperative hydronephrosis after ureteroscopic lithotripsy
por: Kim, Sun Woo, et al.
Publicado: (2016)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Ham, Won Sik, et al.
Publicado: (2021)

Antibiotic Prophylaxis in Radical Prostatectomy: Comparison of 2-Day and More than 2-Day Prophylaxis
por: Shin, Bosung, et al.
Publicado: (2017)

Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy
por: Hwang, Eu Chang, et al.
Publicado: (2016)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
por: Villar, Miriam Méndez-del, et al.
Publicado: (2017)

Accuracy and Factors Affecting the Outcome of Multi-Detector Computerized Tomography Urography for Bladder Tumors in the Clinical Setting
por: Hwang, Eu Chang, et al.
Publicado: (2011)

Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS
por: Noh, Tae Il, et al.
Publicado: (2022)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

Effect of metformin monotherapy and dual or triple concomitant therapy with metformin on glycemic control and lipid profile management of patients with type 2 diabetes mellitus
por: Lin, Yan-Yu, et al.
Publicado: (2022)

Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus
por: Nasykhova, Yulia A., et al.
Publicado: (2022)

Are More Low-Risk Prostate Cancers Detected by Repeated Biopsy? A Retrospective Pilot Study
por: Lee, Seung Je, et al.
Publicado: (2013)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Deceptive Muscle Invasive Bladder Cancer Recurrence With Benign Biopsy Foci After Bladder Sparing Treatment
por: Xu, Chuanliang, et al.
Publicado: (2015)

Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
por: Zhang, Jianglei, et al.
Publicado: (2021)

Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study
por: Kang, Sung Gu, et al.
Publicado: (2016)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence
por: Yu, Seong Hyeon, et al.
Publicado: (2023)

Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2014)

Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial
por: Zhang, Xiuzhen, et al.
Publicado: (2021)

Leptin and the rs2167270 Polymorphism Are Associated with Glycemic Control in Type Two Diabetes Mellitus Patients on Metformin Therapy
por: Alfaqih, Mahmoud A., et al.
Publicado: (2023)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study
por: Hwang, Eu Chang, et al.
Publicado: (2014)

The Efficacy of the EORTC Scoring System and Risk Tables for the Prediction of Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer after Intravesical Bacillus Calmette-Guerin Instillation
por: Seo, Kyung Won, et al.
Publicado: (2010)

Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control
por: Hirst, Jennifer A., et al.
Publicado: (2012)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends
por: Shalata, Aya T., et al.
Publicado: (2022)

Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora
por: Lim, Do Gyeong, et al.
Publicado: (2021)

Development of a patient decision aid for type 2 diabetes mellitus for patients not achieving glycemic control on metformin alone
por: Shillington, Alicia C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ve87j6g2t8apq0eodnimhmodrl